Corporate$IPHA5:21 AM ET

Innate Pharma schedules Q3 2026 conference call for November 5

By BORSA NewsroomPublished Oct 20, 2026, 5:21 AM EDTUpdated Oct 20, 2026, 5:21 AM EDT

Innate Pharma will hold a conference call on November 5, 2026 at 8 a.m. ET to discuss its third-quarter business and financial update. CEO Jonathan Dickinson and other executives will participate.

Sentimentneutral 50

Neutral · 50 of 100

Impact10

low · stays off the top drivers

Confidence95%

high confidence · single wire

Eventdeveloping

v1 · alerted to followers

WHAT WE KNOW

Conference call on November 5, 2026 at 2 p.m. CET / 8 a.m. ET.
Participants: CEO, CMO, COO, CFO, VP IR.